Michael J. LaBarre - 16 Feb 2023 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role: SVP, CHIEF TECHNICAL OFFICER
Signature: /s/ James R. Oehler, Attorney-in-Fact
Issuer symbol: HALO
Transactions as of: 16 Feb 2023
Net transactions value: -$141,770
Form type: 4
Filing time: 21 Feb 2023, 18:05:11 UTC
Previous filing: 17 Feb 2023
Next filing: 19 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HALO	Common Stock	Options Exercise	$0	+6,112	+4.2%	$0.000000	151,805	16 Feb 2023	Direct
transaction	HALO	Common Stock	Sale	$141,770	-2,878	-1.9%	$49.26	148,927	16 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HALO	Restricted Stock Units	Options Exercise	$0	-6,112	-25%	$0.000000	18,336	16 Feb 2023	Common Stock	6,112	$0.000000	Direct	F2
transaction	HALO	Option to Purchase Common Stock	Award	$0	+48,849		$0.000000	48,849	16 Feb 2023	Common Stock	48,849	$49.26	Direct	F3
transaction	HALO	Restricted Stock Units	Award	$0	+17,053		$0.000000	17,053	16 Feb 2023	Common Stock	17,053	$0.000000	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported disposition of 2,878 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F2	This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
F3	This option vests one-fourth on such date and then 1/48th monthly thereafter.
F4	This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.